Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics

Tadashi Iida(Nagoya University), Atsushi Enomoto(Nagoya University), Eizaburo Ohno(Nagoya University), Liang Weng(Peking University), Atsushi Masamune(Tohoku University), Masahide Takahashi(Metropolitan University), Yoshiki Hirooka(Fujita Health University Hospital), Keiko Kuwata(Nagoya University), Mitsuhiro Fujishiro(Bunkyo University), Shinji Mii(Hiroshima University), Yasuyuki Mizutani(Nagoya University), Brian Burkel(University of Wisconsin–Madison), Hiroki Kawashima(Nagoya University Hospital), Hisashi Haga(Hokkaido University), Kunio Kataoka(Nagoya University), Suzanne M. Ponik(University of Wisconsin–Madison), Seiichiro Ishihara(Hokkaido University), Yukihiro Shiraki(Nagoya University), Takuya Ishikawa(Nagoya University), Nobutoshi Esaki(Nagoya University)
Oncogene
April 13, 2022
Cited by 68


Related Papers